Forskning ved Københavns Universitet - Københavns Universitet

Forside

Malignant T cells exhibit CD45 resistant Stat3 activation and proliferation in cutaneous

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Malignant T cells exhibit CD45 resistant Stat3 activation and proliferation in cutaneous. / Krejsgaard, Thorbjørn Frej; Helvad, Rikke; Ralfkiaer, Elisabeth; Astvad, Karin; Grønbæk, Kirsten; Eriksen, Karsten W. ; Geisler, Carsten; Kopp, Katharina Luise Maria; Zhang, Qian ; Ødum, Niels; Andersen, Anders Woetmann.

I: The Open Leukemia Journal, Bind 3, 2010, s. 9-15.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Krejsgaard, TF, Helvad, R, Ralfkiaer, E, Astvad, K, Grønbæk, K, Eriksen, KW, Geisler, C, Kopp, KLM, Zhang, Q, Ødum, N & Andersen, AW 2010, 'Malignant T cells exhibit CD45 resistant Stat3 activation and proliferation in cutaneous', The Open Leukemia Journal, bind 3, s. 9-15. <http://www.benthamscience.com/open/toleukemiaj/articles/V003/9TOLEUKEMIAJ.pdf>

APA

Krejsgaard, T. F., Helvad, R., Ralfkiaer, E., Astvad, K., Grønbæk, K., Eriksen, K. W., Geisler, C., Kopp, K. L. M., Zhang, Q., Ødum, N., & Andersen, A. W. (2010). Malignant T cells exhibit CD45 resistant Stat3 activation and proliferation in cutaneous. The Open Leukemia Journal, 3, 9-15. http://www.benthamscience.com/open/toleukemiaj/articles/V003/9TOLEUKEMIAJ.pdf

Vancouver

Krejsgaard TF, Helvad R, Ralfkiaer E, Astvad K, Grønbæk K, Eriksen KW o.a. Malignant T cells exhibit CD45 resistant Stat3 activation and proliferation in cutaneous. The Open Leukemia Journal. 2010;3:9-15.

Author

Krejsgaard, Thorbjørn Frej ; Helvad, Rikke ; Ralfkiaer, Elisabeth ; Astvad, Karin ; Grønbæk, Kirsten ; Eriksen, Karsten W. ; Geisler, Carsten ; Kopp, Katharina Luise Maria ; Zhang, Qian ; Ødum, Niels ; Andersen, Anders Woetmann. / Malignant T cells exhibit CD45 resistant Stat3 activation and proliferation in cutaneous. I: The Open Leukemia Journal. 2010 ; Bind 3. s. 9-15.

Bibtex

@article{76f6376be4ce43feb3b5909eb9e8177f,
title = "Malignant T cells exhibit CD45 resistant Stat3 activation and proliferation in cutaneous",
abstract = "CD45 is a protein tyrosine phosphatase, which is well-known for regulating antigen receptor signalling in Tand B cells via its effect on Src kinases. It has recently been shown that CD45 can also dephosphorylate Janus kinases(Jaks) and thereby regulate Signal transducer and activator of transcription (Stat) activation and cytokine-inducedproliferation in lymphocytes. Consequently, CD45 dysregulation could be implicated in aberrant Jak/Stat activation andproliferation in lymphoproliferative diseases. Despite high expression of the CD45 ligand, Galectin-1, in skin lesions fromcutaneous T-cell lymphoma (CTCL), the malignant T cells exhibit constitutive activation of the Jak3/Stat3 signallingpathway and uncontrolled proliferation. We show that CD45 expression is down-regulated on malignant T cells whencompared to non-malignant T cells established from CTCL skin lesions. Moreover, CD45 cross-linking does not suppressthe constitutive activation of Stat3 in the malignant T cells and there is no correlation between the level of activated Stat3and the level of CD45 expression on the malignant T cells. Furthermore, in contrast to non-malignant T cells, themalignant T cells are protected against CD45-mediated inhibition of proliferation. In conclusion, our data suggest thatCD45 dysregulation might play a role in the aberrant proliferation and Jak3/Stat3 activation in CTCL.",
author = "Krejsgaard, {Thorbj{\o}rn Frej} and Rikke Helvad and Elisabeth Ralfkiaer and Karin Astvad and Kirsten Gr{\o}nb{\ae}k and Eriksen, {Karsten W.} and Carsten Geisler and Kopp, {Katharina Luise Maria} and Qian Zhang and Niels {\O}dum and Andersen, {Anders Woetmann}",
year = "2010",
language = "English",
volume = "3",
pages = "9--15",
journal = "The Open Leukemia Journal",
issn = "1876-8164",
publisher = "Bentham Open",

}

RIS

TY - JOUR

T1 - Malignant T cells exhibit CD45 resistant Stat3 activation and proliferation in cutaneous

AU - Krejsgaard, Thorbjørn Frej

AU - Helvad, Rikke

AU - Ralfkiaer, Elisabeth

AU - Astvad, Karin

AU - Grønbæk, Kirsten

AU - Eriksen, Karsten W.

AU - Geisler, Carsten

AU - Kopp, Katharina Luise Maria

AU - Zhang, Qian

AU - Ødum, Niels

AU - Andersen, Anders Woetmann

PY - 2010

Y1 - 2010

N2 - CD45 is a protein tyrosine phosphatase, which is well-known for regulating antigen receptor signalling in Tand B cells via its effect on Src kinases. It has recently been shown that CD45 can also dephosphorylate Janus kinases(Jaks) and thereby regulate Signal transducer and activator of transcription (Stat) activation and cytokine-inducedproliferation in lymphocytes. Consequently, CD45 dysregulation could be implicated in aberrant Jak/Stat activation andproliferation in lymphoproliferative diseases. Despite high expression of the CD45 ligand, Galectin-1, in skin lesions fromcutaneous T-cell lymphoma (CTCL), the malignant T cells exhibit constitutive activation of the Jak3/Stat3 signallingpathway and uncontrolled proliferation. We show that CD45 expression is down-regulated on malignant T cells whencompared to non-malignant T cells established from CTCL skin lesions. Moreover, CD45 cross-linking does not suppressthe constitutive activation of Stat3 in the malignant T cells and there is no correlation between the level of activated Stat3and the level of CD45 expression on the malignant T cells. Furthermore, in contrast to non-malignant T cells, themalignant T cells are protected against CD45-mediated inhibition of proliferation. In conclusion, our data suggest thatCD45 dysregulation might play a role in the aberrant proliferation and Jak3/Stat3 activation in CTCL.

AB - CD45 is a protein tyrosine phosphatase, which is well-known for regulating antigen receptor signalling in Tand B cells via its effect on Src kinases. It has recently been shown that CD45 can also dephosphorylate Janus kinases(Jaks) and thereby regulate Signal transducer and activator of transcription (Stat) activation and cytokine-inducedproliferation in lymphocytes. Consequently, CD45 dysregulation could be implicated in aberrant Jak/Stat activation andproliferation in lymphoproliferative diseases. Despite high expression of the CD45 ligand, Galectin-1, in skin lesions fromcutaneous T-cell lymphoma (CTCL), the malignant T cells exhibit constitutive activation of the Jak3/Stat3 signallingpathway and uncontrolled proliferation. We show that CD45 expression is down-regulated on malignant T cells whencompared to non-malignant T cells established from CTCL skin lesions. Moreover, CD45 cross-linking does not suppressthe constitutive activation of Stat3 in the malignant T cells and there is no correlation between the level of activated Stat3and the level of CD45 expression on the malignant T cells. Furthermore, in contrast to non-malignant T cells, themalignant T cells are protected against CD45-mediated inhibition of proliferation. In conclusion, our data suggest thatCD45 dysregulation might play a role in the aberrant proliferation and Jak3/Stat3 activation in CTCL.

M3 - Journal article

VL - 3

SP - 9

EP - 15

JO - The Open Leukemia Journal

JF - The Open Leukemia Journal

SN - 1876-8164

ER -

ID: 33934057